BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1284 related articles for article (PubMed ID: 23916937)

  • 1. N-terminal pro-B-type natriuretic peptide and its relationship with cardiac function in adults with congenital heart disease.
    Eindhoven JA; van den Bosch AE; Ruys TP; Opić P; Cuypers JA; McGhie JS; Witsenburg M; Boersma E; Roos-Hesselink JW
    J Am Coll Cardiol; 2013 Sep; 62(13):1203-12. PubMed ID: 23916937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations between N-terminal pro-B-type natriuretic peptide and cardiac function in adults with corrected tetralogy of Fallot.
    Eindhoven JA; Menting ME; van den Bosch AE; Cuypers JA; Ruys TP; Witsenburg M; McGhie JS; Boersma E; Roos-Hesselink JW
    Int J Cardiol; 2014 Jul; 174(3):550-6. PubMed ID: 24798786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The significance of N-terminal pro-B natriuretic peptide in the management of adult patients with congenital heart disease - Results from the CSONGRAD Registry].
    Ambrus N; Havasi K; Berek K; Kalapos A; Hartyánszky I; Bogáts G; Forster T; Nemes A
    Orv Hetil; 2018 Jan; 159(4):141-148. PubMed ID: 29353497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma N-terminal pro-brain natriuretic peptide as a marker of right ventricular dysfunction in patients with tetralogy of Fallot after surgical repair.
    Norozi K; Buchhorn R; Kaiser C; Hess G; Grunewald RW; Binder L; Wessel A
    Chest; 2005 Oct; 128(4):2563-70. PubMed ID: 16236924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of exercise capacity with cardiopulmonary exercise test and B-type natriuretic peptide in adults with congenital heart disease.
    Trojnarska O; Gwizdała A; Katarzyński S; Katarzyńska A; Szyszka A; Lanocha M; Grajek S; Kramer L
    Cardiol J; 2009; 16(2):133-41. PubMed ID: 19387960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation of N-Terminal Pro-B-Type Natriuretic Peptide and Left Ventricular Diastolic Function to Exercise Tolerance in Patients With Significant Valvular Heart Disease and Normal Left Ventricular Systolic Function.
    Hwang JW; Park SJ; Cho EJ; Kim EK; Lee GY; Chang SA; Choi JO; Lee SC; Park SW
    Am J Cardiol; 2017 Jun; 119(11):1846-1853. PubMed ID: 28391990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Values of brain natriuretic peptide and N-terminal pro-brain natriuretic peptide in evaluation of cardiac function in children with congenital heart disease].
    Zhang SR; Zhang YH; Xu Q; Qiu HX; Chen Q
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jun; 11(6):429-32. PubMed ID: 19558803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide, Troponin-T, and Growth-Differentiation Factor 15 in Adult Congenital Heart Disease.
    Baggen VJ; van den Bosch AE; Eindhoven JA; Schut AW; Cuypers JA; Witsenburg M; de Waart M; van Schaik RH; Zijlstra F; Boersma E; Roos-Hesselink JW
    Circulation; 2017 Jan; 135(3):264-279. PubMed ID: 27832613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NT-proBNP Indicates Left Ventricular Impairment and Adverse Clinical Outcome in Patients With Tetralogy of Fallot and Pulmonary Regurgitation.
    Westhoff-Bleck M; Kornau F; Haghikia A; Horke A; Bertram H; Treptau J; Widder J; Bauersachs J; Brehm MU
    Can J Cardiol; 2016 Oct; 32(10):1247.e29-1247.e36. PubMed ID: 26927857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of biventricular functional reserve and NT-proBNP levels in patients with RV volume overload after repair of tetralogy of Fallot at young age.
    van den Berg J; Strengers JL; Wielopolski PA; Hop WC; Meijboom FJ; de Rijke YB; Boomsma F; Bogers AJ; Pattynama PM; Helbing WA
    Int J Cardiol; 2009 Apr; 133(3):364-70. PubMed ID: 18495276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
    J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive value of B-type natriuretic peptides in detecting latent left ventricular diastolic dysfunction in beta-thalassemia major.
    Kremastinos DT; Hamodraka E; Parissis J; Tsiapras D; Dima K; Maisel A
    Am Heart J; 2010 Jan; 159(1):68-74. PubMed ID: 20102869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The diagnostic value of N-terminal B-type natriuretic peptide in diastolic heart failure: comparison with echocardiographic findings].
    Tuğcu A; Yildirimtürk O; Aytekin S
    Turk Kardiyol Dern Ars; 2009 Mar; 37(2):112-21. PubMed ID: 19404033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Range and distribution of NT-proBNP values in stable corrected congenital heart disease of various types.
    Popelová J; Kotaška K; Černý S; Prokopová M; Rubáček M
    Can J Cardiol; 2012; 28(4):471-6. PubMed ID: 22482396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Personal experience with determination of NT-proBNP in clinical practice].
    Stejskal D; Oral I; Lacnák B; Juráková R; Horalík D; Adamovská S; Prosková J; Hrabovská I; Ozanová G
    Vnitr Lek; 2003 Feb; 49(2):121-6. PubMed ID: 12728579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incremental value of N-terminal pro-brain natriuretic peptide over left ventricle ejection fraction and aerobic capacity for estimating prognosis in heart failure patients.
    Kallistratos MS; Dritsas A; Laoutaris ID; Cokkinos DV
    J Heart Lung Transplant; 2008 Nov; 27(11):1251-6. PubMed ID: 18971099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between N-terminal B-type natriuretic propeptide and right ventricular performance assessed by tissue Doppler imaging and speckle tracking echocardiography in children after surgical repair of tetralogy of Fallot.
    Pietrzak R; Werner B
    Kardiol Pol; 2015; 73(1):24-30. PubMed ID: 25764994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [N-terminal pro-brain natriuretic peptide (NT-proBNP) and ischemia modified albumin (IMA) in exercise induced ischemia in patients with stable coronary artery disease].
    Piechota WN; Wierzbowski R; Piechota WT; Bejm J; Gielerak G
    Pol Arch Med Wewn; 2006 Jul; 116(1):640-7. PubMed ID: 17340970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of N-terminal pro brain natriuretic peptide levels in different types of Fontan circulation.
    Heck PB; Müller J; Weber R; Hager A
    Eur J Heart Fail; 2013 Jun; 15(6):644-9. PubMed ID: 23610138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Value of Serial N-Terminal Pro-B-Type Natriuretic Peptide Measurements in Adults With Congenital Heart Disease.
    Baggen VJM; Baart SJ; van den Bosch AE; Eindhoven JA; Witsenburg M; Cuypers JAAE; Roos-Hesselink JW; Boersma E
    J Am Heart Assoc; 2018 Mar; 7(7):. PubMed ID: 29581225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 65.